Related Experiment Video
Updated: Dec 23, 2025

Micromanipulation of Circulating Tumor Cells for Downstream Molecular Analysis and Metastatic Potential Assessment
Published on: May 14, 2019
Integrative Analysis and Machine Learning based Characterization of Single Circulating Tumor Cells.
Arvind Iyer1, Krishan Gupta2, Shreya Sharma2
1Department of Computational Biology, Indraprastha Institute of Information Technology, New Delhi 110020, India.
Circulating tumor cells (CTCs) across cancers exhibit a continuous epithelial to mesenchymal transition (EMT) spectrum. This finding aids in developing classifiers for detecting CTCs and understanding cancer immunotherapy targets like PD-L1 and MHC.
Area of Science:
- Oncology
- Genomics
- Immunology
Background:
- Circulating tumor cells (CTCs) are crucial biomarkers for cancer detection, prognosis, and treatment monitoring.
- Understanding the heterogeneity of CTCs, particularly their epithelial-to-mesenchymal transition (EMT) status, is vital for effective cancer management.
- The interplay between PD-L1 and MHC expression in CTCs may influence response to cancer immunotherapy.
Purpose of the Study:
- To analyze the transcriptomic profiles of CTCs across various cancer types.
- To investigate the relationship between EMT and gene expression patterns, including PD-L1 and MHC, in CTCs.
- To develop and validate a classifier for accurate CTC identification using gene expression data.
Main Methods:
- Collated and analyzed publicly available single-cell RNA sequencing data of CTCs from diverse cancers.
- Performed integrative analysis of CTC transcriptomes to identify key gene expression patterns.
- Trained a machine learning classifier using CTC and peripheral blood mononuclear cell (PBMC) expression profiles.
- Validated the classifier using CTCs captured by a novel label-free microfluidic enrichment system.
Main Results:
- CTCs from different cancers demonstrate a continuous spectrum of EMT.
- An inverse correlation between PD-L1 and MHC gene expression was observed in CTCs.
- A classifier was successfully trained to recognize diverse CTC phenotypes with high accuracy.
- The classifier validated the presence of circulating breast tumor cells isolated via the new microfluidic device.
Conclusions:
- The EMT continuum in CTCs provides a unified model for understanding CTC biology across cancers.
- The identified PD-L1/MHC expression pattern offers insights into immune evasion mechanisms and potential immunotherapy targets.
- The developed classifier represents a promising tool for CTC detection and characterization.
- The study validates a novel microfluidic system for CTC enrichment and analysis.
More Related Videos
09:45Microfluidics-based High-throughput Circulating Tumor Cell Sorting and Single-cell Sequencing Technology
Published on: November 14, 2025
10:29Semi-automatic PD-L1 Characterization and Enumeration of Circulating Tumor Cells from Non-small Cell Lung Cancer Patients by Immunofluorescence
Published on: August 14, 2019